Doctors said an antibiotic-resistant bacterium known as Klebsiella pneumoniae has killed as many as 200 patients in hospitals across Israel.
Elderly patients and people with weak immune systems are particularly vulnerable to the bacterium, Arutz Sheva reported.
Epidemiologist Yehuda Carmeli of the Sourasky Medical Center in Tel Aviv said 400 to 500 people have been infected by the bug.
"Thirty to forty percent of them have already died," Carmeli told YNetNews. "However, it is important to note that most of them were in a serious condition, and some were suffering from prior medical conditions."
Infectious diseases specialist Dr. Galia Rahav told Israel's Channel 1 that 130 patients at Sheba Hospital have become infected. One-third of those patients have died.
YNetNews said the Israeli Health Ministry has set up a committee of experts to "determine the scope of the problem and advise hospitals on how to contain it."
Copyright 2007 by United Press International
Related stories:
3 share Nobel prize for work on AIDS and cancer
(AP) -- Three European scientists shared the 2008 Nobel Prize in medicine on Monday for separate discoveries of viruses that cause AIDS and cervical cancer, breakthroughs that helped doctors fight the deadly diseases.
HIV patients still stung by stigma from health-care providers
The doctor who wouldn’t come into the patient’s hospital room. The neurologist who avoided eye contact. The ambulance attendant who angrily threw her bloodied gloves into the street after learning the injured patient was HIV-positive.
Bacteria that cause urinary tract infections invade bladder cells
Scientists at Washington University School of Medicine in St. Louis have found definitive proof that some of the bacteria that plague women with urinary tract infections (UTIs) are entrenched inside human bladder cells.
New class of drug offers hope to treatment-resistant AIDS patients
For the estimated millions of AIDS patients worldwide who are resistant or are developing resistance to currently available medicines, a discovery by a University of Georgia researcher may offer a new treatment option by targeting a previously elusive enzyme in the complex retrovirus responsible for the devastating disease.
Norwalk virus: 'Cruise ship' illness challenging and costly to hospitals, too
A review of measures taken to address a 2004 outbreak of the highly infectious Norwalk virus at The Johns Hopkins Hospital has provided the first solid documentation of expenses and efforts in the United States to stop the infection from spreading among patients, staff and visitors. Total hospital costs for the three-month outbreak - including extra cleaning supplies, staff sick leave, diagnostic tests, replacement staff, and salaries and lost revenue from closed beds - were estimated at more than $650,000.
Study group at risk for human mad cow form
Blood donors and recipients participating in a British study have been warned that they may be at risk for the human form of mad cow disease.
WHO warns of drug-resistant TB
The World Health Organization in Switzerland has warned of a new strain of tuberculosis that is rapidly spreading and cannot be treated with current drugs.
Russia readies bird flu vaccines
Russia is conducting clinical trials of bird flu vaccines by which it hopes to avoid a bird-flu pandemic that could affect up to one-third of the population.